More on IVVD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+8.3% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Invivyd (NQ:IVVD)
Delayed: 0.69 -0.05 (6.76%)
Prev. Close $0.74  
Open$0.74 
52 Wk High$ 
52 Wk Low$ 
Day High$0.77 
Day Low$0.68 
P/E N/A  
EPS$ 
Volume2,723,514 

Friends, Peers and Foes (?): IDIA, NBP SANN (more...)

Jul 8, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Jul 6, 2026 07:12 AM Form 8-K Invivyd, Inc. For: Jul 06
Jul 6, 2026 07:06 AM FDA notifies Invivyd that Pemgarda EUA will end June 2027
Jul 6, 2026 07:01 AM Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
Jul 2, 2026 07:01 AM Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 29, 2026 07:00 AM NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
Jun 16, 2026 07:01 AM INVIVYD completes enrollment in Phase 3 COVID antibody trial
Jun 16, 2026 07:01 AM Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Jun 16, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Jun 9, 2026 07:01 AM Invivyd begins Phase 3 trial comparing COVID antibody to mRNA vaccine
View All Articles

Entities mentioned with IVVD

View All Entities